CL
RVMDW icon

CSS LLC’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

CSS LLC’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.61M Buy
78,367
+60,862
+348% +$329K 0.26% 69
2026
Q1 		$282K Sell
17,505
-1,940
-10% -$3.76K 0.01% 673
2025
Q4 		$164K Hold
19,445
– – 0.01% 791
2025
Q3 		$52.4K Sell
19,445
-16,402
-46% -$3.98K ﹤0.01% 899
2025
Q2 		$84.7K Sell
35,847
-15,541
-30% -$2.31K ﹤0.01% 849
2025
Q1 		$17.6K Buy
51,388
+25,120
+96% +$3.12K ﹤0.01% 871
2024
Q4 		$42.5K Buy
26,268
+9,607
+58% +$2.84K ﹤0.01% 901
2024
Q3 		$21K Buy
16,661
+1,658
+11% +$202 ﹤0.01% 777
2024
Q2 		$13.8K Buy
15,003
+147
+1% +$30 ﹤0.01% 831
2024
Q1 		$24.4K Buy
14,856
+2,975
+25% +$602 ﹤0.01% 757
2023
Q4 		$35.3K Buy
+11,881
New +$5.31K ﹤0.01% 733

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

CSS LLC's RVMDW Position: Q2 2026 in Review

CSS LLC increased its Revolution Medicines Inc Warrant (RVMDW) stake by 348% in Q2 2026, buying an estimated $329K and bringing the position to 78,367 shares worth $6.61M. The position accounts for 0.26% of the portfolio, ranked #69.

CSS LLC first reported a position in RVMDW in Q4 2023 and has held it in 11 quarters since. 22 funds tracked by Wall St. Rank hold RVMDW as of Q2 2026.

  • CSS LLC held 78,367 shares of Revolution Medicines Inc Warrant worth $6.61M as of Q2 2026.
  • CSS LLC bought 60,862 Revolution Medicines Inc Warrant shares in Q2 2026, an estimated $329K.
  • Revolution Medicines Inc Warrant made up 0.26% of CSS LLC's portfolio in Q2 2026, its #69 holding.
  • CSS LLC first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and has held it in 11 quarters since.
  • 22 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q2 2026.

Based on CSS LLC's 13F filing for Q2 2026, filed 14 Aug 2026.